ID   CBiPSC6.2
AC   CVCL_RM92
SY   CBiPS-6.2; CB6.2; Cord Blood iPSC clone 6.2; CCRIi001-A; TMOi001-A; Gibco Human Episomal iPSC; A18945; PCBC03hsi2011080401; SC11-008
DR   BioSamples; SAMEA2253216
DR   GEO; GSM860998
DR   GEO; GSM1084836
DR   GEO; GSM1084908
DR   GEO; GSM1084909
DR   GEO; GSM1084988
DR   GEO; GSM1085026
DR   GEO; GSM1589803
DR   GEO; GSM1589815
DR   GEO; GSM1589935
DR   GEO; GSM1589947
DR   hPSCreg; TMOi001-A
DR   Wikidata; Q54808665
RX   PubMed=21494607;
RX   PubMed=22905176;
RX   PubMed=27293150;
RX   PubMed=27688775;
RX   PubMed=34419745;
RX   PubMed=34479069;
WW   https://www.thermofisher.com/order/catalog/product/A18945
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Miscellaneous: Age/sex of donor and identity of CBiPSC6.2 with Gibco cell line from personal communication of Zambidis E.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=34479069
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 9,15
ST   FGA: 22,25
ST   Penta D: 2.2,11
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM93 ! CBiPSC6.11
OI   CVCL_RM94 ! CBiPSC6.13
OI   CVCL_RM95 ! CBiPSC19.11
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 11
//
RX   PubMed=21494607; DOI=10.1371/journal.pone.0018293;
RA   Burridge P.W., Thompson S., Millrod M.A., Weinberg S., Yuan X.,
RA   Peters A., Mahairaki V., Koliatsos V.E., Tung L., Zambidis E.T.;
RT   "A universal system for highly efficient cardiac differentiation of
RT   human induced pluripotent stem cells that eliminates interline
RT   variability.";
RL   PLoS ONE 6:E18293-E18293(2011).
//
RX   PubMed=22905176; DOI=10.1371/journal.pone.0042838;
RA   Park T.S., Huo J.S., Peters A., Talbot C.C. Jr., Verma K.,
RA   Zimmerlin L., Kaplan I.M., Zambidis E.T.;
RT   "Growth factor-activated stem cell circuits and stromal signals
RT   cooperatively accelerate non-integrated iPSC reprogramming of human
RT   myeloid progenitors.";
RL   PLoS ONE 7:E42838-E42838(2012).
//
RX   PubMed=27293150; DOI=10.1016/j.stemcr.2016.05.006;
RA   Salomonis N., Dexheimer P.J., Omberg L., Schroll R., Bush S., Huo J.,
RA   Schriml L.M., Sui S.H., Keddache M., Mayhew C.N., Shanmukhappa S.K.,
RA   Wells J.M., Daily K., Hubler S., Wang Y.-L., Zambidis E.T., Margolin A.A.,
RA   Hide W.A., Hatzopoulos A.K., Malik P., Cancelas J.A., Aronow B.J.,
RA   Lutzko C.;
RT   "Integrated genomic analysis of diverse induced pluripotent stem cells
RT   from the Progenitor Cell Biology Consortium.";
RL   Stem Cell Reports 7:110-125(2016).
//
RX   PubMed=27688775; DOI=10.1155/2016/3826249;
RA   Nagaria P.K., Robert C., Park T.S., Huo J.S., Zambidis E.T.,
RA   Rassool F.V.;
RT   "High-fidelity reprogrammed human IPSCs have a high efficacy of DNA
RT   repair and resemble hESCs in their MYC transcriptional signature.";
RL   Stem Cells Int. 2016:3826249.1-3826249.14(2016).
//
RX   PubMed=34419745; DOI=10.1016/j.scr.2021.102506;
RA   Mazza M.C., Beylina A., Roosen D.A., Hauser D., Cookson M.R.;
RT   "Generation of iPSC line from a Parkinson patient with PARK7 mutation
RT   and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7
RT   mutation.";
RL   Stem Cell Res. 55:102506-102506(2021).
//
RX   PubMed=34479069; DOI=10.1016/j.scr.2021.102520;
RA   Krumm L., Pozner T., Kaindl J., Regensburger M., Gunther C., Turan S.,
RA   Asadollahi R., Rauch A., Winner B.;
RT   "Generation and characterization of an endogenously tagged SPG11-human
RT   iPSC line by CRISPR/Cas9 mediated knock-in.";
RL   Stem Cell Res. 56:102520-102520(2021).
//